THC Tenet Healthcare Corporation New SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC

THC Stock Analysis: Buy, Sell, or Hold?

$290.27
+1.27 (+0.44%) ▲
5d: +8.84% 30d: +8.0% 90d: +8.8%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (19%)
Quality Score
47/100
Position
EXTENDED
30-Day Fair Range
$258.59 – $273.80
Position: EXTENDED
Forward P/E & Valuation
14.3x STRETCHED
vs 11.8x historical avg
Wall Street Target
$305.50
+5.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$255.50 / $301.44
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: THC shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When THC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$203.40
Based on -3.2% avg growth
INTRINSIC VALUE TODAY
$126.29
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: THC is currently trading at $290.27, which is considered extended relative to its 30-day fair value range of $258.59 to $273.80. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.2) compared to its historical average (11.8). At these levels, the market is pricing in 6.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, THC is in a strong uptrend. Immediate support is located at $255.50, while resistance sits at $301.44.

Market Sentiment: THC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $258.59 - $273.80
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 19.0%

Trading Range & Key Levels

30-Day Trading Range $258.59 - $273.80
Current vs Trading Range EXTENDED
Support Level $255.50
Resistance Level $301.44
Current Trend Strong Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding THC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range (+6.0% above its trading range)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($305.50)
  • NEUTRAL: PE elevated vs history but 6.4% growth expectation is conservative given 222% recent growth
  • WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 14.25
Wall Street Target $305.50 (+5.2%)
Revenue Growth (YoY) 6.5%
Earnings Growth (YoY) 221.5%
Profit Margin 13.1%
Valuation Premium vs History +6.4% premium
PE vs Historical 14.3 vs 11.8 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.4% (market-implied from PE analysis)
1-Year Target $308.85 (+6%)
2-Year Target $328.61 (+13%)
3-Year Target $349.64 (+21%)
3-Yr Target (if PE normalizes) (PE: 14→12) PE COMPRESSION $289.49 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -10.3%) $294.87 (+2%)
Base: (SPY PE: 14.3, Growth: -10.3%) $211.61 (-27%)
Bear: (PE: 11.8, Growth: -10.3%) $175.20 (-40%)
📈 Valuation based on Current Earnings
Trailing PE: 8.43 | Current EPS (TTM): $34.29
Bull Case $188.82 (-35%)
Analyst growth -40.6%, PE expands to 9.3
Base Case $171.66 (-41%)
Market implied -40.6%, PE stable at 8.4
Bear Case $196.52 (-32%)
Severe decline -20.0%, PE contracts to 7.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share THC Analysis

Share this live THC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (THC)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits is bullish on $THC with a P/E ratio less than 10, while the latest Yahoo Finance news article discusses two undervalued stocks, Kroger ($KR) and United Rentals ($URI), with strong revenue growth and efficient business models.
Key Retail Themes: Undervalued stocks Growth potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:52 AM ET
Data refreshes hourly during market hours. Next update: 6:52 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is THC showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for THC.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CMPS
Compass Pathways Plc 		STRONG BUY
16 analysts 		$24 55 HOLD
HCA
HCA Healthcare, Inc. 		BUY
26 analysts 		$477 39 SELL
EHC
Encompass Health Corp 		STRONG BUY
13 analysts 		$156 34 SELL
CON
Concentra Group Holdings… 		STRONG BUY
11 analysts 		$44 41 HOLD
ADUS
Addus HomeCare Corporati… 		STRONG BUY
14 analysts 		$140 45 HOLD
CMPS Compass Pathways …
55 HOLD
HCA HCA Healthcare, I…
39 SELL
EHC Encompass Health …
34 SELL
CON Concentra Group H…
41 HOLD
ADUS Addus HomeCare Co…
45 HOLD

Advanced THC Option Strategies

Professional options setups generated by AI based on today's THC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive THC Research Pages
THC Technical Chart THC Price Prediction THC Intrinsic Value DCF THC Earnings Date THC Investment Advisor THC Fair Price Analyzer THC Options Chain THC Options Advisor THC Options Analysis THC Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (THC) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare THC with Peers
THC vs HCA
Which one to buy?
THC vs UHS
Which one to buy?
THC vs CYH
Which one to buy?
THC vs HUM
Which one to buy?
THC vs CI
Which one to buy?
THC vs DVA
THC vs FMS
Winner: THC
SGRY vs THC
Winner: THC
THC vs OPCH
HCA vs THC
Winner: THC
UHS vs THC
THC vs CHE
EHC vs THC
THC vs CI
Winner: CI
ENSG vs THC
Winner: THC
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals